Yahoo India Web Search

Search results

1. www.researchgate.net › profile › Igor-Bondarenko-2Igor BONDARENKO | Head of Department | Doctor of Philosophy ...

   www.researchgate.net › profile › Igor-Bondarenko-2

   Igor BONDARENKO, Head of Department | Cited by 26,199 | | Read 213 publications | Contact Igor BONDARENKO

2. Images

   • 
   • 
   • 
   • 
   • 

   View all

3. www.researchgate.net › profile › Igor-Bondarenko-2Igor BONDARENKO | Head of Department | Doctor of Philosophy ...

   www.researchgate.net › profile › Igor-Bondarenko-2

   Medical University of Vienna. Igor BONDARENKO, Head of Department | Cited by 26,838 | | Read 214 publications | Contact Igor BONDARENKO.

4. www.seamgroup.com › leadership › igor-bondarenkoIgor Bondarenko, SEAM Group Chief Technology Officer (CTO)

   www.seamgroup.com › leadership › igor-bondarenko

   • Cached

   Igor Bondarenko is the Chief Technology Officer (CTO) at SEAM Group, leading the company’s technology product, application, infrastructure strategy, and vision.

5. www.diaglobal.org › en › course-listingPresenters - DIA Global

   www.diaglobal.org › en › course-listing

   • Cached

   Igor Bondarenko is the head of Oncology and Medical Radiology Department of Dnipropetrovsk Medical Academy (Ukraine) since 2000. Igor Bondarenko has created the first in Ukraine center for clinical trials, where oncology treatment is provided by international partners.

6. www.linkedin.com › in › igbondarenkoIgor Bondarenko - Cleveland, Ohio, United States ... - LinkedIn

   www.linkedin.com › in › igbondarenko

   Location: Cleveland · 500+ connections on LinkedIn. View Igor Bondarenko’s profile on LinkedIn, a professional community of 1 billion members.

   • Connections: 500+

   • Followers: 1.1K

7. isom.ca › profile › igor-bondarenkoIgor Bondarenko - ISOM

   isom.ca › profile › igor-bondarenko

   • Cached

   Igor Bondarenko, MD, Prof (Biochemistry) Biography. After presenting his PhD thesis, Dr Bondarenko studied Laboratory Immunodiagnosis, and then – Clinical Laboratory Diagnosis (in St. Petersburg, Sweden, and Finland), with a special attention to Clinical Biochemistry.

8. People also ask

   Who is Igor Bondarenko?

   • Igor Bondarenko is the Chief Technology Officer at SEAM Group. He has overall responsibility for establishing the company’s technology product, application, and infrastructure strategy. He also leads innovations in all forms of technology across the business as well as ensures a secure and resilient infrastructure to support the organization.

   Igor Bondarenko, SEAM Group Chief Technology Officer (CTO)

   www.seamgroup.com/about-us/leadership/igor-bondarenko/

   See all results for this question

   Who is Prof Bondarenko?

   • At present, Prof Bondarenko is working as a Research Council Member of Health Guard, an organisation promoting nutritional supplementation in the prevention and post-treatment support in oncology (Warszawa, Poland), and as a Senior Researcher at the Medical Institute for Nutrition Science and Technology (Riga, Latvia).

   Igor Bondarenko - ISOM

   isom.ca/profile/igor-bondarenko/

   See all results for this question

   Who is Igor seam?

   • Prior to joining SEAM Group, Igor was the Director Cloud Engineering at Elastic. He also spent time at IBM Watson Health as the Director of Software Development, and earlier served as the Director of Technology for American Greetings. Igor completed his education at the National Technical University of Ukraine Kyiv Polytechnic Institute.

   Igor Bondarenko, SEAM Group Chief Technology Officer (CTO)

   www.seamgroup.com/about-us/leadership/igor-bondarenko/

   See all results for this question

9. orcid.org › 0000/0002/7071-2471Igor Bondarenko (0000-0002-7071-2471) - ORCID

   orcid.org › 0000/0002/7071-2471

   Igor Bondarenko. expand_more. Works (50 of 436) sort Sort. Items per page: 50. Page 1 of 9. Durvalumab ± Tremelimumab plus Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden. Clinical Cancer Research. 2024 | Journal article. DOI: 10.1158/1078-0432.CCR-23-1689.